These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Use of gabapentin to reduce chronic neuropathic pain in Fabry disease.
    Author: Ries M, Mengel E, Kutschke G, Kim KS, Birklein F, Krummenauer F, Beck M.
    Journal: J Inherit Metab Dis; 2003; 26(4):413-4. PubMed ID: 12971431.
    Abstract:
    The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15-45 years. After 4 weeks of treatment, pain, as measured using the Brief Pain Inventory, was decreased compared with baseline. Treatment was generally well tolerated. This study indicates that gabapentin should be considered as a treatment option for the neuropathic pain of Fabry disease.
    [Abstract] [Full Text] [Related] [New Search]